EpiPens, the leading brand of epinephrine autoinjectors used to treat anaphylaxis, have been in short supply since November, 2017. The product, which administers epinephrine intramuscularly, is simple enough to be used by parents, teachers, or friends at the first sign of anaphylaxis.
